MGC Pharmaceuticals Limited - MGCLF

MGC Pharmaceuticals Limited operates as a medical and cosmetic cannabis company in Australia and Slovenia. It is developing phytocannabinoid as active pharmaceutical ingredients containing medicinal cannabis products. The company is also developing product formulation groups, including MGCND00EP1 for neurological disorders; MGCON00CA1 for oncology treatment and side effects; and MGCAU00SD1 for autoimmune treatments in inflammatory cases, as well as deep skin relief products under the DermaPlus brand. In addition, it provides the raw materials and matched genetics to treat patients that live with various diseases. MGC Pharmaceuticals Limited has a strategic collaboration agreement with Royal Melbourne Institute of Technology; and a strategic partnership with IEB AS. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited is based in West Perth, Australia.